Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services
Home » Publications » Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services
Questo sito utilizza i cookie per analisi statistiche: continuando la navigazione ne accetti l'uso
